MAPT and Alzheimer disease: Conversely, activation of CB1 receptor by enhancing endocannabinoid tone has been shown to inhibit Tau phosphorylation in animal models of AD and, in some cases, to ameliorate cognitive functions (Hashem et al., 2021).